Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Isotype Controls and Standards
  5. anti-IgG1 κ, Rat, FITC, Clone: R3-34, Isotype Control, BD

anti-IgG1 κ, Rat, FITC, Clone: R3-34, Isotype Control, BD

Catalog No. BDB552916 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.1 mg
0.25 mg
50 Tests
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB552916 50 Tests
BDB554684 0.1 mg
BDB553924 0.25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Catalog No. BDB552916 Supplier BD Biosciences Supplier No. 552916
Only null left
Add to Cart
Add to Cart

Description

The immunoglobulin from the R3-34 hybridoma was identified as a non-reactive clone, following immunization with mouse Ig. The R3-34 immunoglobulin was selected as an isotype control following screening for low background on a variety of mouse and human tissues. This antibody is routinely tested by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.

Host Species: Rat
Clone: R3-34
Isotype: IgG1, κ

Flow Cytometry, Intracellular Staining, Isotype Control

TRUSTED_SUSTAINABILITY

Specifications

Applications Flow Cytometry, Western Blot
Clone R3-34
Conjugate FITC
Host Species Rat
Purification Method Affinity Purified
Quantity 50 Tests
Content And Storage Undiluted at 4°C
Isotype IgG1 κ
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.